Understanding Synthetic Lethality: The Backup-Pathway Logic…

What Synthetic Lethality Is

Synthetic lethality occurs when the simultaneous mutation or knockout of two genes results in cell death, even though each gene alone may not be harmful. This phenomenon is crucial for understanding how certain cancer cells can be selectively targeted with drugs.

In the context of BRCA-mutant cancers, synthetic lethality has been exploited to develop PARP inhibitors, which target cells that have lost their ability to repair DNA damage through homologous recombination.

The Backup-Pathway Logic

Cells rely on multiple pathways for repairing damaged DNA. When one pathway is compromised (e.g., due to a BRCA1 mutation), the cell may still have another backup pathway available. However, if both pathways are disrupted simultaneously, the cell cannot repair its DNA and dies.

This principle forms the basis of synthetic lethality: by targeting two genes that together are essential for survival but individually are not, cancer cells can be selectively killed while normal cells remain unaffected.

live demo · related simulation● LIVE

How Synthetic Lethality is Exploited in Cancer Therapy

Synthetic lethality has been harnessed to develop targeted therapies such as PARP inhibitors. These drugs block the second backup pathway, leading to cell death in BRCA-mutant cancer cells.

By understanding and utilizing synthetic lethality, researchers can design more effective and less toxic treatments for cancers with specific genetic mutations.

Real-World Examples of Synthetic Lethality

The most well-known example is the use of PARP inhibitors in BRCA-mutant breast and ovarian cancers. These drugs exploit the synthetic lethality between BRCA1/2 mutations and defects in homologous recombination repair.

Other examples include targeting the combination of BCR-ABL and c-KIT mutations in chronic myeloid leukemia, where both genes are individually non-lethal but together they lead to cell death.

Frequently asked questions

What is a backup pathway in DNA repair?

A backup pathway in DNA repair refers to an alternative mechanism that cells can use when their primary repair system is compromised. This allows the cell to continue functioning until it can switch back to its usual repair process.

Why are BRCA1 and BRCA2 mutations significant in synthetic lethality?

BRCA1 and BRCA2 mutations impair homologous recombination, a key DNA repair mechanism. When both genes are mutated, cells lose their ability to repair double-strand breaks effectively, leading to cell death through synthetic lethality.

Can synthetic lethality be used for other types of cancer?

Yes, synthetic lethality can be applied to various cancers with specific genetic mutations. For example, it has been explored in lung cancer, prostate cancer, and others where certain gene combinations can lead to cell death.

How does the Synthetic Lethality Explorer help researchers?

The Synthetic Lethality Explorer allows researchers to visualize and predict synthetic lethality interactions within a genetic network. This tool aids in identifying potential therapeutic targets and understanding complex genetic interactions that can lead to cell death.

Try it live

Everything above runs in your browser — open Synthetic Lethality Explorer (2D) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Synthetic Lethality Explorer (2D) simulation

Understanding Synthetic Lethality: The Backup-Pathway Logic Behind Cancer Therapy